Caroline Kessler advises a variety of companies in the U.S. health care industry. Her clients include hospitals and health systems, academic medical centers, and pharmaceutical and device companies. She focuses on regulatory and transactional matters related to food and drug law, as well as Medicare and Medicaid reimbursement.

Caroline assists clients in the pharmaceutical, biotechnology, medical device and food industries with complex matters relating to government regulation implemented by the U.S. Food and Drug Administration (FDA). Her work primarily includes advising clients with respect to laws and regulations related to the development and commercialization of pharmaceutical products, medical devices and other health technologies, including FDA labeling and promotional matters.

Additionally, Caroline represents health care providers and other clients in connection with health care policy implemented by the Centers for Medicare and Medicaid Services (CMS).

Prior to attending law school, Caroline was a staff member in the office of Sen. Angus S. King, Jr. (I-ME), as well as at the Harvard T.H. Chan School of Public Health.

While in law school, Caroline served as an executive editor of the Virginia Law Review and as the president of the Health Law Association. She also interned with the Vaccine Litigation Unit in the U.S. Department of Justice.

Caroline was a member of Akin Gump’s 2018 summer associate class.